Delivery Order SPE2DB24D8002-SPE2DB25FJNSL

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,197.08, is for the delivery of SAVELLA 50 MG TABLET 60S, a medical product. The contract has an ultimate completion date of February 27, 2025 and is a firm fixed-price delivery order contract. The contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,789.32 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRINTELLIX 5 MG TABLET 30S, a pharmaceutical product, with a period of performance through September 24, 2024. This delivery order is placed under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, identified as SPE2DB24D8001 and...
This is a $6,848.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SAVELLA 25 MG TABLET 60S, a medication, with a period of performance through March 12, 2025. This contract is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of pharmaceutical products, medical supplies, and healthcare equipment, with a focus on supporting U.S. Armed Forces medical operations. The contract has a ceiling value of $3,151.10 and an ultimate completion date of May 8, 2025. It is part of the DLA Troop Support Medical's ECAT Generation...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $15,860.63, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of March 20, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The award, with a ceiling value of $1,844.88, is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001 and valued at $999,999,999.00. This IDC is part...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $5,761.21, is for the delivery of 270 tablets of the pharmaceutical product Renvela 800 mg. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a broader indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,042.84, is for the delivery of 4,567,372,214 lisdexamfetamine 40 mg capsules, to be completed by February 26, 2025. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,506.31 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products,...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,504.35 contract is for the supply of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical products,...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJNSL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $7,865.62 firm fixed-price contract is for the delivery of SAVELLA 50 MG TABLET 60S, a pharmaceutical product.

The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between DLA Troop Support Medical and Dakota Drug, Inc. under the ECAT Generation V Program. This IDC allows Dakota Drug, Inc. to efficiently deliver a broad range of critical medical supplies, including various pharmaceuticals and healthcare equipment, to support U.S. Armed Forces medical operations.

Generated 8/18/25, 9:45 AM